United States 117th Congress Status: In Committee Bipartisan · 6 D · 1 R cosponsors

HR 467 — Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021

Last action — Referred to the Subcommittee on Health.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 117th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021 This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.

Bill Text

How this bill changes current law

4 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill expands existing law to require coverage of certain COVID-19 antibody treatments without cost sharing under group health plans and health insurance issuers.

  • 42 U.S.C. 256b note

    or antibody treatment, as applicable

    Adds coverage for antibody treatments to the existing provisions for diagnostic testing.

  • 42 U.S.C. 256b note

    and antibody treatments

    Expands the reimbursement header to include antibody treatments.

  • 42 U.S.C. 256b note

    or antibody treatment

    Ensures that the provisions include antibody treatments in the context of reimbursement for testing.

  • 42 U.S.C. 256b note

    or treatment (including the administration of such treatment)

    Clarifies coverage eligibility to include administration of antibody treatments.

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

  4. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  7. Referred to the Subcommittee on Health.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 6 co-sponsors · 540 not signed on

Sponsors (1)

Co-sponsors (6)

Not signed on (540)

540 members have not signed on to this bill.

Show all 540 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 467 do?
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021 This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
Who sponsors HR 467?
HR 467 is sponsored by Spanberger, Abigail Davis (Democratic), Jackson Lee, Sheila (Democratic), Ryan, Tim (Democratic), Ross, Deborah K. (Democratic), Neguse, Joe (Democratic), Gottheimer, Josh (Democratic), and Gonzalez, Anthony (Republican).
What is the current status of HR 467?
This bill died with 117th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 467?
Track HR 467 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 467

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 467

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →